Our website is set to allow the use of cookies for certain functionalities. For more information click here.

Select a localised edition of our website

Forward-thinking international law firm

Matthew Royle, Tim Worden and Paul England of Taylor Wessing discuss the issues raised by Brexit for the authorisation of medicinal products and medical devices, and how the available exclusivity rights for these products may be affected.

${expertFirstname} ${expertSurname}

${expertJobtitle} | ${expertOffice}

{{if expertProfileimage!="99999999"}}
{{if expertMobile!=""}}

Next Event